Lepidext was founded by Dr. Angelika Fath-Goodin and Dr. Bruce Webb, who realized that a strain of a naturally-occurring corn earworm virus that caused fewer latent cases would have potential as a biocontrol for the corn earworm
Lepidext successfully identified the strain
Lepidext obtained a patent on it
Lepidext tested the efficacy of this product in the laboratory for a few years, and improved production methods and insect rearing capacity
Lepidext performed the first field trials of this product in the Summer of 2020, which demonstrated transmission in the field and showed the potential of the technology
In the coming years, Lepidext will complete larger efficacy field trials and scale the technology for commercialization
MEET OUR TEAM
Bruce Webb, Ph.D.
Founder & President
Angelika Fath-Goodin, Ph.D.
Maria Labreveux, Ph.D.
Executive in Residence
Michael “Andy” Anderson
Systems Production Analyst
Megha Kalsi, Ph.D.
Project Lead Sr. Scientist
Mergers & Acquisitions Attorney
Former COO ADM, Bluegrass Angel, KY farmer